Zobrazeno 1 - 10
of 224
pro vyhledávání: '"Jc, Chermann"'
Autor:
Trabaud C, Dessolin J, Camplo M, Hantz O, Fabien Zoulim, Borel C, Meyer M, Pepe G, Jc, Chermann, Jl, Kraus
Publikováno v:
Europe PubMed Central
A number of N,N',N",N"'-tetrakis (omega-aminoalkyl) tetraazamacrocycles and related compounds were synthesized and evaluated for their inhibitory effects on human immunodeficiency virus type 1 (HIV-1) and duck hepatitis B virus (DHBV) replication. Th
Autor:
Chassagne J, Verrelle P, Dionet C, Clavel F, Barre-Sinoussi F, Jc, Chermann, Montagnier L, Jc, Gluckman, David Klatzmann
Publikováno v:
Europe PubMed Central
A murine monoclonal antibody (MAb), named C.V.K., was produced after immunization with highly purified and sonicated lymphadenopathy-associated virus (LAV). No monoclonal antibody was observed with intact virus used as immunogen. C.V.K. MAb recognize
Autor:
Montagnier L, Jc, Chermann, Barré-Sinoussi F, David Klatzmann, Wain-Hobson S, Alizon M, Clavel F, Brun-Vezinet F, Vilmer E, Rouzioux C
Publikováno v:
Europe PubMed Central
Lymphadenopathy associated virus (LAV) is a novel human retrovirus first reported in 1983. It was isolated from the lymph node lymphocytes of a French homosexual patient with generalized hyperplasic lymphadenopathy. Subsequently LAV was isolated from
Autor:
Gout O, Rouquette B, Elisabeth Tournier-Lasserve, Barre-Sinoussi F, Lyon-Caen O, Jc, Chermann
Publikováno v:
Europe PubMed Central
We observed the development of an acute encephalopathy in a healthy human immunodeficiency virus (HIV) seropositive man. HIV was isolated from cerebrospinal fluid but not from peripheral blood. Signs and symptoms resolved quickly without treatment. T
Autor:
Cl, Parravicini, Vago L, Gc, Costanzi, Jc, Gluckman, David Klatzmann, Berti E, Barre-Sinoussi F, Jc, Chermann, Lazzarin A, Moroni M
Publikováno v:
Europe PubMed Central
This study deals with the immunohistochemistry of a monoclonal antibody (Mab) raised against the p18 protein of the LAV virus in lymphnodes from 20 cases of persistent generalized lymphoadenopathy (PGL) (2) and 6 of acquired immunodeficiency syndrome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::8918accb1071359409cbc2b193ae6ebf
http://europepmc.org/abstract/med/3004544
http://europepmc.org/abstract/med/3004544
Autor:
Bouhlal R; Laboratoire de Biotechnologie et Chimie Marines (LBCM), Centre de recherche Yves Coppens, Université européenne de Bretagne (UEB), Université de Bretagne-Sud. Vannes, France.; Laboratoire de Diversité et Conservation de Systèmes Biologiques (LDICOSYB), Faculté de Science, Université Abdelmalek Essaâdi, Tétouan, Maroc. B.P. 2121, 93003, Morocco., Haslin C; URRMA R&D, Centre de vie agora, bâtiment C, B.P. 1055, Z.I. des paluds, 13781 Aubagne Cedex, France., Chermann JC; URRMA R&D, Centre de vie agora, bâtiment C, B.P. 1055, Z.I. des paluds, 13781 Aubagne Cedex, France., Colliec-Jouault S; Laboratoire Biotechnologies et Molécules Marines, IFREMER, B.P. 21105 44311 Nantes, France., Sinquin C; Laboratoire Biotechnologies et Molécules Marines, IFREMER, B.P. 21105 44311 Nantes, France., Simon G; Université européenne de Bretagne, Université de Bretagne Occidentale, Service Commun de Résonance Magnétique Nucléaire, UFR Sciences et Techniques, Avenue Le Gorgeu, CS 93837 29238 Brest Cedex 3, France., Cerantola S; Université européenne de Bretagne, Université de Bretagne Occidentale, Service Commun de Résonance Magnétique Nucléaire, UFR Sciences et Techniques, Avenue Le Gorgeu, CS 93837 29238 Brest Cedex 3, France., Riadi H; Laboratoire de Diversité et Conservation de Systèmes Biologiques (LDICOSYB), Faculté de Science, Université Abdelmalek Essaâdi, Tétouan, Maroc. B.P. 2121, 93003, Morocco., Bourgougnon N; Laboratoire de Biotechnologie et Chimie Marines (LBCM), Centre de recherche Yves Coppens, Université européenne de Bretagne (UEB), Université de Bretagne-Sud. Vannes, France.
Publikováno v:
Marine drugs [Mar Drugs] 2011; Vol. 9 (7), pp. 1187-1209. Date of Electronic Publication: 2011 Jul 06.
Autor:
Haslin C; URRMA R&D, Aubagne Cedex, France. hasliln@urrma.fr, Lévêque M, Ozil A, Cérutti P, Chardès T, Chermann JC, Duonor-Cérutti M
Publikováno v:
Human antibodies [Hum Antibodies] 2007; Vol. 16 (3-4), pp. 73-85.
Autor:
Barré-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Vézinet-Brun F, Rouzioux C, Rozenbaum W, Montagnier L
Publikováno v:
Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion [Rev Invest Clin] 2004 Mar-Apr; Vol. 56 (2), pp. 126-9.
Autor:
Haslin C; URRMA R&D, Centre de Vie Agora, ZI des Paluds, BP 1055, 13781 Cedex, Aubagne, France. cherma@urrma.fr, Chermann JC
Publikováno v:
Current opinion in biotechnology [Curr Opin Biotechnol] 2002 Dec; Vol. 13 (6), pp. 621-4.
Autor:
Xu X; Department of Infectious Diseases, the First Hospital, Beijing University, Beijing 100034,China., Xing H, Gong W, Chen H, Si C, Wang Y, Chermann JC
Publikováno v:
Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology [Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi] 2002 Sep; Vol. 16 (3), pp. 286-7.